Acetylcholinesterase Enzyme Among Cancer Patients a Potential Diagnostic and Prognostic Indicator a Multicenter Case-control Study

Overview

Journal Sci Rep

Specialty Science

Date 2024 Mar 1

PMID 38429330

Authors

Gasmelseed Y Ahmed

Ahmed A Osman

Ahlam Mukhtar

Affiliations

Soon will be listed here.

Abstract

Acetylcholinesterase enzyme (AChE) activity is impaired by a variety of inhibitors including organophosphorus pesticides, leading to the accumulation of acetylcholine. In this study, we aimed to determine the association between cancer and the blood level of the (AChE). This is a multicenter hospital-based case-control study conducted in the Radiation and Isotopes Center Khartoum, and Institute of Nuclear Medicine and Molecular Biology and Oncology Gezira. One hundred and fifty participants, half of them cancer patients and half cancer free were recruited. All participants were screened for demographic, environmental, occupational, and clinical characteristics. Blood for the (AChE) activity test was drawn from participants in the two groups. The mean age of the participants was 40.6 ± 14.8 years. Geographical distribution showed the Central Region of Sudan had the highest rate of cancer, followed by North State, Khartoum State, West State, and East State. The most common tumor subtype was breast cancer, followed by leukemia, colon, esophageal, and prostate cancer. Inferential analysis revealed significantly impaired (AChE) activity among cancer patients compared to controls (53.4 ± 20.3% vs. 93.8 ± 8.8, p-value 0.001). There was a significant statistical association between impaired (AChE) activity and cancer. (AChE) activity might be applied in the future as a diagnostic biomarker and therapeutic target. Further large sample and molecular studies are recommended.

References

Chen J, Cheuk I, Shin V, Kwong A . Acetylcholine receptors: Key players in cancer development. Surg Oncol. 2019; 31:46-53. DOI: 10.1016/j.suronc.2019.09.003. View

Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C . Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology. 2013; 81(4):322-8. DOI: 10.1212/WNL.0b013e31829c5ec1. View

Munoz J, Calaf G . Acetylcholine, Another Factor in Breast Cancer. Biology (Basel). 2023; 12(11). PMC: 10669196. DOI: 10.3390/biology12111418. View

Ospina-Romero M, Abdiwahab E, Kobayashi L, Filshtein T, Brenowitz W, Mayeda E . Rate of Memory Change Before and After Cancer Diagnosis. JAMA Netw Open. 2019; 2(6):e196160. PMC: 6593639. DOI: 10.1001/jamanetworkopen.2019.6160. View

colovic M, Krstic D, Lazarevic-Pasti T, Bondzic A, Vasic V . Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013; 11(3):315-35. PMC: 3648782. DOI: 10.2174/1570159X11311030006. View

Perez-Aguilar B, Marquardt J, Munoz-Delgado E, Lopez-Duran R, Gutierrez-Ruiz M, Gomez-Quiroz L . Changes in the Acetylcholinesterase Enzymatic Activity in Tumor Development and Progression. Cancers (Basel). 2023; 15(18). PMC: 10526250. DOI: 10.3390/cancers15184629. View

Kasiotis K, Kyriakopoulou K, Emmanouil C, Tsantila N, Liesivuori J, Souki H . Monitoring of systemic exposure to plant protection products and DNA damage in orchard workers. Toxicol Lett. 2011; 210(2):182-8. DOI: 10.1016/j.toxlet.2011.10.020. View

Martinez-Moreno P, Nieto-Ceron S, Torres-Lanzas J, Ruiz-Espejo F, Tovar-Zapata I, Martinez-Hernandez P . Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis. 2005; 27(3):429-36. DOI: 10.1093/carcin/bgi250. View

Zhao Y, Wang X, Wang T, Hu X, Hui X, Yan M . Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology. 2011; 53(2):493-503. DOI: 10.1002/hep.24079. View

10.

Martinez-Lopez de Castro A, Nieto-Ceron S, Aurelio P, Galbis-Martinez L, Latour-Perez J, Torres-Lanzas J . Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond). 2008; 115(8):245-53. DOI: 10.1042/CS20070393. View

11.

Irizar P, Schauble S, Esser D, Groth M, Frahm C, Priebe S . Transcriptomic alterations during ageing reflect the shift from cancer to degenerative diseases in the elderly. Nat Commun. 2018; 9(1):327. PMC: 5790807. DOI: 10.1038/s41467-017-02395-2. View

12.

Perez-Aguilar B, Vidal C, Palomec G, Garcia-Dolores F, Gutierrez-Ruiz M, Bucio L . Acetylcholinesterase is associated with a decrease in cell proliferation of hepatocellular carcinoma cells. Biochim Biophys Acta. 2015; 1852(7):1380-7. DOI: 10.1016/j.bbadis.2015.04.003. View

13.

McHardy S, Wang H, McCowen S, Valdez M . Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). Expert Opin Ther Pat. 2016; 27(4):455-476. DOI: 10.1080/13543776.2017.1272571. View

14.

Driver J . Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014; 15(6):547-57. DOI: 10.1007/s10522-014-9523-2. View

15.

Mattiuzzi C, Lippi G . Current Cancer Epidemiology. J Epidemiol Glob Health. 2019; 9(4):217-222. PMC: 7310786. DOI: 10.2991/jegh.k.191008.001. View

16.

Tohgi H, Abe T, Kimura M, SAHEKI M, Takahashi S . Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm (Vienna). 1996; 103(10):1211-20. DOI: 10.1007/BF01271206. View

17.

Park S, Kim N, Yoo Y . Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res. 2004; 64(8):2652-5. DOI: 10.1158/0008-5472.can-04-0649. View

18.

Sharma S . Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol. 2010; 30(1):1-8. PMC: 2902207. DOI: 10.4103/0971-5851.56328. View

19.

Hedtke V, Bakovic M . Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1. Exp Biol Med (Maywood). 2019; 244(8):655-662. PMC: 6552397. DOI: 10.1177/1535370219830997. View

20.

Anand P, Kunnumakkara A, Kunnumakara A, Sundaram C, Harikumar K, Tharakan S . Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008; 25(9):2097-116. PMC: 2515569. DOI: 10.1007/s11095-008-9661-9. View